Science 37 Holdings, Inc. (SNCE)

Market Cap	47.64M
Revenue (ttm)	61.62M
Net Income (ttm)	-134.26M
Shares Out	117.11M
EPS (ttm)	-1.14
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	542,310
Open	0.360
Previous Close	0.371
Day's Range	0.360 - 0.410
52-Week Range	0.190 - 1.990
Beta	1.30
Analysts	Buy
Price Target	2.00 (+391.64%)
Earnings Date	Nov 9, 2023

About SNCE

Science 37 Holdings, Inc. engages in patient-centric clinical trial activities in North Carolina. Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and sponsors, standardize evidence generation, and harmonize data. The company's platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating clinical trials; and extensive configuration to support v...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2014
• Employees: 460
• Stock Exchange: NASDAQ
• Ticker Symbol: SNCE

Financial Performance

In 2022, Science 37's revenue was $70.15 million, an increase of 17.70% compared to the previous year's $59.60 million. Losses were -$50.99 million, -45.95% less than in 2021.

Analyst Forecast

According to 3 analysts, the average rating for SNCE stock is "Buy." The 12-month stock price forecast is $2.0, which is an increase of 391.64% from the latest price.

Price Target

$2.0

(391.64% upside)

Analyst Consensus: Buy